Dr. Adarsh Vennepureddy
Claim this profileAultman Health Foundation
Studies Colorectal Cancer
Studies Cancer
9 reported clinical trials
30 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage II
Stage I
2Cancer
Stage IV
ER positive
PR positive
Affiliated Hospitals
Clinical Trials Adarsh Vennepureddy is currently running
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
Fulvestrant + Binimetinib
for Breast Cancer
This trial is testing whether adding binimetinib to the usual treatment of fulvestrant can help patients with a specific type of advanced breast cancer. Fulvestrant works by blocking estrogen receptors on cancer cells, while binimetinib stops enzymes that help cancer grow. The goal is to see if this combination can better control the cancer compared to using fulvestrant alone.
Recruiting1 award Phase 219 criteria
More about Adarsh Vennepureddy
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Adarsh Vennepureddy has experience with
- Binimetinib
- Fulvestrant
- Selumetinib Sulfate
- Paclitaxel
- Ipatasertib
- Olaparib
Breakdown of trials Adarsh Vennepureddy has run
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adarsh Vennepureddy specialize in?
Adarsh Vennepureddy focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage II.
Is Adarsh Vennepureddy currently recruiting for clinical trials?
Yes, Adarsh Vennepureddy is currently recruiting for 7 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Adarsh Vennepureddy has studied deeply?
Yes, Adarsh Vennepureddy has studied treatments such as Binimetinib, Fulvestrant, Selumetinib Sulfate.
What is the best way to schedule an appointment with Adarsh Vennepureddy?
Apply for one of the trials that Adarsh Vennepureddy is conducting.
What is the office address of Adarsh Vennepureddy?
The office of Adarsh Vennepureddy is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.